- Home
- SXTC vs FDMT Comparison
SXTC vs FDMT Comparison
Compare SXTC & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SXTC
- FDMT
- Stock Information
- Founded
- SXTC 2005
- FDMT 2013
- Country
- SXTC China
- FDMT United States
- Employees
- SXTC N/A
- FDMT N/A
- Industry
- SXTC Biotechnology: Pharmaceutical Preparations
- FDMT Biotechnology: Pharmaceutical Preparations
- Sector
- SXTC Health Care
- FDMT Health Care
- Exchange
- SXTC Nasdaq
- FDMT Nasdaq
- Market Cap
- SXTC 164.8M
- FDMT 192.2M
- IPO Year
- SXTC 2019
- FDMT 2020
- Fundamental
- Price
- SXTC $1.61
- FDMT $7.27
- Analyst Decision
- SXTC
- FDMT Buy
- Analyst Count
- SXTC 0
- FDMT 9
- Target Price
- SXTC N/A
- FDMT $30.63
- AVG Volume (30 Days)
- SXTC 490.3K
- FDMT 750.8K
- Earning Date
- SXTC 01-01-0001
- FDMT 08-11-2025
- Dividend Yield
- SXTC N/A
- FDMT N/A
- EPS Growth
- SXTC N/A
- FDMT N/A
- EPS
- SXTC N/A
- FDMT N/A
- Revenue
- SXTC $1,740,907.00
- FDMT $33,000.00
- Revenue This Year
- SXTC N/A
- FDMT $9,921.62
- Revenue Next Year
- SXTC N/A
- FDMT N/A
- P/E Ratio
- SXTC N/A
- FDMT N/A
- Revenue Growth
- SXTC N/A
- FDMT N/A
- 52 Week Low
- SXTC $0.95
- FDMT $2.24
- 52 Week High
- SXTC $7.84
- FDMT $17.41
- Technical
- Relative Strength Index (RSI)
- SXTC 54.54
- FDMT 64.99
- Support Level
- SXTC $1.41
- FDMT $6.09
- Resistance Level
- SXTC $1.59
- FDMT $7.33
- Average True Range (ATR)
- SXTC 0.12
- FDMT 0.50
- MACD
- SXTC 0.00
- FDMT -0.06
- Stochastic Oscillator
- SXTC 93.20
- FDMT 80.25
About SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.